| Application no. and date | 14766474.2 (espacenet) (Federated) (European Patent Register), 20140916 | | Patent/reg. no. and date | DK/EP 3046536, 20181128 | | Publication date | 20160727 | | Priority no. and date | EP 13185200, 20130919 | | EP pub. no. and date |
EP 3046536 20160727 | | Effective date | | | Applicant/owner | Janssen Vaccines & Prevention B.V., Archimedesweg 4
2333 CN Leiden, NL | | Applicant ref. no. | Janssen Vaccines & Prevention B.V. 0219EP00PCT | | Inventor | ADRIAANSEN, Janik, Archimedesweg 4-6
NL-2333 CN Leiden, NL | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 35/76 (2015.01) , A61K 47/02 (2006.01) , A61K 47/10 (2017.01) , A61K 47/12 (2006.01) , A61K 47/18 (2017.01) , A61K 47/26 (2006.01) , A61K 47/40 (2006.01) , A61K 9/00 (2006.01) , A61K 9/08 (2006.01) , C12N 15/86 (2006.01) | | Title | FORBEDREDE ADENOVIRUSFORMULERINGER | | Int. application no. | EP2014069654 | | Int. publication no. | WO2015040002 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
